Founded with a mission to extend human healthspan and improve quality of life, Juvenescence is a biotech company focused on developing therapies and products aimed at modifying the aging process. The company envisions a future where aging can be managed and mitigated through scientific innovation. Juvenescence offers a range of therapeutic solutions designed to promote longevity and enhance cognitive health, leveraging cutting-edge research in areas such as ketones' impact on performance.
Notable figures affiliated with Juvenescence include Dr. Brianna Stubbs, who has been instrumental in researching the cognitive benefits of ketones. The company has attracted significant investment from leading venture capital firms in the biotech sector. Among its key achievements, Juvenescence has made strides in developing novel therapies that have the potential to revolutionize how aging is treated, thereby making a substantial impact on the field of longevity science.
